Connect with us

Events

Reimagining women’s health with WHIS 2025

Published

on

There is an increasing recognition that investing in women’s health is both a moral and an economic imperative.

Women represent half of the global population and are often the primary healthcare decision-makers for their families.

Yet, historically, women’s health has been underfunded and underserved in clinical research and healthcare policies.

This has created gaps in access to care and a lack of representation of women’s health needs in medical advancements.

For the past six years, the Women’s Health Innovation Series has been a leading force in advancing women’s health.

Now, as part of its ongoing mission to increase access and accelerate innovations for the health of women, the series has undergone a transformative rebrand – expanding its scope to offer a more comprehensive, integrated approach to the diverse and complex landscape of women’s health.

By integrating their previous FemTech and Reproductive Health events under one dynamic umbrella, WHIS is reimagining how the industry engages and tackles the most critical conversations and challenges faced in women’s healthcare.

This rebrand signals a shift towards a more holistic approach—one that seeks to address systemic barriers in healthcare delivery, policy, and technology.

The Need for a Holistic Approach to Women’s Health

Historically, women’s health has been viewed primarily through the lens of reproductive and maternal health.

However, today’s healthcare landscape recognises that women face unique health challenges that require a comprehensive approach, one that encompasses physical, emotional, and mental well-being throughout the lifespan.

This holistic approach is at the core of WHIS 2025, with the event emphasising the importance of shifting the focus from isolated health conditions to integrated, patient-centred care.

As women live longer, there is an increasing need to address ageing-related conditions, such as osteoporosis, dementia, and cardiovascular diseases—conditions that affect women differently than men.

Chronic conditions like heart disease, for example, have long been studied from a male-centric perspective but require a more nuanced understanding when it comes to women’s health.

Medtronic’s President of Heart, Nina Goodheart will delve into how existing medical interventions are supporting the health of women against cardiovascular disease.

She will focus on advancements in treatment options, the critical role of early detection, personalised care, and preventative strategies.

By taking a holistic view of women’s health, healthcare systems can ensure that women receive the comprehensive care they need to thrive at every stage of life.

Reducing Barriers to Access

A holistic approach also means tackling the significant barriers women face when trying to access care.

Many women experience additional challenges such as caregiving responsibilities, financial constraints, and inadequate insurance coverage, which contribute to delayed diagnoses, poorer health outcomes, and increased strain on women, particularly in underserved communities.

To address these inequities, there is a growing recognition that a shift toward value-based care is essential.

Unlike the traditional fee-for-service models, which prioritise the volume of services provided, value-based care emphasises the importance of improving patient outcomes.

Dianne Balon, SVP of Government at Blue Cross Alberta, will discuss the importance of conveying the value of preventative care and interventions to payers.

By demonstrating the long-term benefits of investing in women’s health—through improved outcomes and reduced long-term costs—healthcare providers can make a compelling case to insurers for broader access to women’s health services.

Fertility and Maternal Health

Fertility and maternal health continue to be major areas of concern, particularly in the U.S., where access to fertility treatments remains difficult for many due to high costs, limited insurance coverage, and geographical barriers.

These systemic issues prevent many women and families from accessing the reproductive care they need, creating significant disparities in maternal health outcomes.

Neel Shah, Chief Medical Officer at Maven Clinic, will dive into the complexities of the U.S. fertility landscape.

He will address the financial and policy barriers that prevent equitable access to IVF and other fertility treatments, discussing innovative solutions, such as expanding fertility benefits through employer-sponsored insurance, telemedicine, and other models that could help democratize access to fertility services.

Additionally, a woman’s journey to motherhood is far from linear, and providing comprehensive care throughout pregnancy, delivery, and the postpartum period is essential.

This holistic approach includes addressing mental health challenges like postpartum depression and providing access to services such as prenatal education, lactation support, and childcare. 

However, traditional reimbursement models often fail to support the long-term, continuous care needed to address the full spectrum of maternal health needs.

As a result, many women are left without the comprehensive support they need during these critical life stages.

Empowering Women Through Data and Technology

As women’s health continues to evolve, the role of consumer and digital health technologies is becoming increasingly important in shaping the future of care.

Wearables, connected health devices, and consumer-driven health solutions are providing women with more control over their well-being, empowering them to monitor a wide range of health metrics.

Dorothy Kilroy, Chief Commercial Officer at OURA will explore the transformative potential of wearable technologies and connected health devices in empowering women to take charge of their health. his empowerment also extends to how women engage with healthcare providers.

By sharing real-time data with clinicians, women can benefit from more personalised care plans, early detection of health issues, and targeted preventative measures.

WHIS 2025 is rethinking how women’s health is perceived and addressed – shifting from a fragmented, isolated approach to one that prioritises holistic, integrated care throughout a women’s lifespan. 

By bringing together leaders from across the entire healthcare continuum, the WHIS 2025 will catalyse critical conversations and actions to reshape the healthcare system’s approach to the unique challenges women face. 

Registration for WHIS 2025 is now open and you can benefit from an exclusive discount on top of their lowest ticket price (book before May 9).

Use code FTW10 for an additional 10% off.

Register Here. 

Special

AHA campaign to raise awareness of heart disease in women

Published

on

Fashion, beauty and lifestyle retailers have joined the American Heart Association to raise awareness of heart disease in women.

The Go Red. Shop with Heart. campaign launched at the New York Stock Exchange on 30 January.

Retailers will ask for donations at checkout in February or donate a percentage of proceeds from selected items.

More than four in 10 women in the US have some form of cardiovascular disease, a term for heart and blood vessel conditions such as heart disease and stroke.

Heart disease and stroke kill more women in the US each year than all forms of cancer combined.

Brands taking part include Away, Commando, Lafayette 148, Michael Kors, Reebok, ShopSimon.com, Summersalt, Torrid and White & Warren.

More than 40 other nationwide retailers are also inviting customers to support the organisation this February through its Life Is Why campaign.

Nancy Brown is chief executive officer of the American Heart Association.

She said: “Nearly 1 in 3 women die from cardiovascular disease each year, yet women are still profoundly under-represented in the clinical research, science and medicine that could save their lives.

“Retailers and consumers are uniquely positioned to turn everyday moments into meaningful change through Go Red. Shop with Heart.”

According to the American Heart Association 2026 Heart Disease and Stroke Statistics Update, heart disease is the leading cause of death in the US and stroke is the number four cause of death.

The organisation projects that at least six in 10 US adults will have cardiovascular disease within the next 30 years and related costs are expected to triple.

However, approximately 80 per cent of cardiovascular disease is preventable through lifestyle changes.

Mindy Grossman is a volunteer board member at the American Heart Association and partner and vice chair of Consello.

Grossman said: “Retail has always been a powerful connector.

“Shop with Heart gives our industry a shared platform to lead with purpose and unite consumers in support of heart health.”

Continue Reading

Features

Women’s Health Week Europe 2026 to take place at the home of Arsenal football club

Published

on

Women’s Health Week Europe is returning to London this year, from the 7–8 October, with the Emirates Stadium now confirmed as the official venue for the event.

Following a sold-out 2025 conference at the Barbican Centre, the move to Emirates Stadium marks a significant scale-up to match the momentum of the industry.

The 2026 event is expected to welcome 800+ attendees, with the entire ecosystem represented, from innovators and investors, to corporates, clinicians, and policymakers across two dedicated tracks focused on advancing women’s health through partnership and commercial growth.

Find out more about WHW Europe 2026 here.

Why the Emirates Stadium?

The WHW team have selected the Emirates Stadium not only for its scale, but for its symbolism.

As one of the most recognisable venues in European sport, the stadium represents what becomes possible when women are given the platform, infrastructure, and investment required to perform at the highest level.

The setting reflects Women’s Health Week’s ambition to position women’s health as a global priority at the intersection of healthcare, capital, sport, and economic growth.

Registration for Women’s Health Week Europe 2026 is now open, with an additional 50 per cent off super early bird pricing available until the end of Friday 30th January.

Further announcements, including speaker confirmations and agenda highlights, will be released in the coming months.

Make sure you don’t miss out, register your interest here.

Continue Reading

News

Merck launces MENA femtech accelerator

Published

on

Merck has launched a MENA femtech accelerator with Qatar Science & Technology Park to back startups improving women’s health.

The QSTP x Merck FemTech Accelerator aims to identify and support up to 30 startups developing solutions across women’s health, with a focus on innovations powered by artificial intelligence, robotics and materials science.

Selected companies will receive scaling support, market entry pathways and pilot opportunities to support commercial expansion into Qatar and the wider region.

Ahmed Aboelfadl, general manager for the Gulf at Merck, said: “Women’s health remains one of the most under-addressed areas in healthcare innovation globally.

“Through this partnership with QSTP, Merck is proud to support the growth of FemTech companies developing science- and technology-led solutions that can meaningfully improve health outcomes for women.

“By combining global scientific expertise with regional collaboration, this initiative will help accelerate innovation, enable real-world impact, and strengthen the ecosystem for women’s health across Qatar and the wider MENA region.”

The programme will feature a two-week immersion in Doha, where founders will engage with clinicians, regulators, investors and innovation leaders.

Rama Chakaki, president of QSTP, said: “At QSTP, we believe that meaningful innovation is inclusive.

“This accelerator is designed to support high-potential startups and generate measurable, scalable impact on women’s health across multiple markets.

“Leveraging Qatar’s growing innovation ecosystem alongside Merck’s global scientific leadership, we are creating pathways for FemTech solutions to be piloted, validated and adopted at regional and global scale.”

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.